Table 1.
Different combinations of ITN/ITN-PBO/IRS/LSM and the associated annual cases averted and costs, total and per person
| ITN | ITN-PBO | IRS | LSM | Cases averted (thousands) | Total costs (million USD) | Cost per case averted (USD) |
|---|---|---|---|---|---|---|
| 0% | 0% | 40% | 68 (9–143) | 9.9 (5.0–14.9) | 146 (556–104) | |
| 80% | 0% | 0% | 71 (29–31) | 1.8 (1.7–1.9) | 25 (59–61) | |
| 0% | 80% | 0% | 75 (16–99) | 58.6 (31.7–84.2) | 781 (1981–851) | |
| 80% | 80% | 40% | 172 (39–301) | 70.3 (38.4–100.9) | 409 (985–335) | |
| 80% | 0% | 0% | 139 (60–157) | 3.5 (2.9–3.7) | 25 (48–24) | |
| 80% | 80% | 207 (70–33) | 64.6 (37.2–90.8) | 312 (531–2752) | ||
| 80% | 80% | 210 (49–361) | 16.0 (10.6–21.5) | 76 (216–60) | ||
| 80% | 80% | 40% | 302 (79–879) | 72.0 (39.9–102.5) | 238 (512–117) |
ITN/ITN-PBO/IRS values refer to the usage/coverage among the population exposed to A. stephensi introduction and LSM the reduction in adult emergence of the established A. stephensi. Values in brackets for the cases averted refer to the difference in minimum and maximum 95% CIs, and as such, the cases averted median value does not always fall within this or in numerical order. Total costs and costs per case refer to the median cases averted, and the range in the brackets as the minimum and maximum costs defined in the Additional File